Home › Graft-Versus-Host Disease › California › Baldwin Park
Graft-Versus-Host Disease clinical trials in Baldwin Park, CA
4 studies for Graft-Versus-Host Disease are looking for participants at sites in and around Baldwin Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
RecruitingPhase 2
- City of Hope Medical Center, Duarte · 4 mi away
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- City of Hope National Medical Center, Duarte · 4 mi away
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
Graft-Versus-Host Disease trials in other cities
- Boston, MA10 studies
- New York City, NY7 studies
- Columbus, OH6 studies
- Atlanta, GA5 studies
- Washington, DC5 studies
- Tampa, FL4 studies
- Pittsburgh, PA4 studies
- St. Louis, MO4 studies
- Detroit, MI4 studies
- Portland, OR4 studies
- Miami, FL4 studies
- Queens, NY4 studies
Other studies in Baldwin Park
- Breast Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Colorectal Cancer38 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)33 studies
- Prostate Cancer30 studies
- Metastatic Cancer30 studies
- Myelodysplastic Syndromes26 studies
- Ovarian Cancer25 studies
- Lung Cancer24 studies
- Multiple Myeloma23 studies
- Stomach Cancer22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.